Impact of HIV Treatment on Quality of Life in South Africa
Author Information
Author(s): Louwagie Goedele M, Bachmann Max O, Meyer Kobus, Booysen Frikkie le R, Fairall Lara R, Heunis Christo
Primary Institution: University of Pretoria
Hypothesis
Does Highly Active Antiretroviral Treatment (HAART) improve health-related quality of life (HRQoL) in HIV positive patients?
Conclusion
HAART was associated with improved HRQoL in patients enrolled in a public sector treatment program in South Africa.
Supporting Evidence
- Patients receiving HAART reported better HRQoL for 3 of the 5 EuroQol dimensions.
- Patients on HAART had a higher mean EuroQol index compared to those awaiting treatment.
- Higher mean VAS scores were reported for patients receiving HAART.
Takeaway
People with HIV who are getting treatment feel better than those who are waiting for treatment.
Methodology
A cross-sectional interview survey was conducted with a stratified random sample of patients receiving or awaiting HAART, using the EuroQol questionnaire to measure HRQoL.
Potential Biases
As a non-randomized trial, the study could be biased by unmeasured confounders.
Limitations
The study was cross-sectional, which limits causal inferences, and treatment duration for many respondents was too short to fully capture HAART effects.
Participant Demographics
The sample included 371 patients, predominantly young (75% aged <43 years), with a higher proportion of women (65%) and largely unemployed (85%).
Statistical Information
P-Value
0.019
Confidence Interval
0.04; 0.23
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website